Urinary concentrations of morphine and codeine after consumption of poppy seedsAnalytics of nonpeptidic erythropoietin mimetic agents in sports drug testing employing high-resolution/high-accuracy liquid chromatography-mass spectrometry.Identification and quantification of the plasma volume expander dextran in human urine by liquid chromatography-tandem mass spectrometry of enzymatically derived isomaltose.High amounts of 17-methylated anabolic-androgenic steroids in effervescent tablets on the dietary supplement market.Clenbuterol marketed as dietary supplement.Insulins in equine urine: qualitative analysis by immunoaffinity purification and liquid chromatography/tandem mass spectrometry for doping control purposes in horse-racing.Rapid screening of polysaccharide-based plasma volume expanders dextran and hydroxyethyl starch in human urine by liquid chromatography-tandem mass spectrometry.Electrospray ionization mass spectrometric characterization and quantitation of xanthine derivatives using isotopically labelled analogues: an application for equine doping control analysis.Examples of doping control analysis by liquid chromatography-tandem mass spectrometry: ephedrines, beta-receptor blocking agents, diuretics, sympathomimetics, and cross-linked hemoglobins.Mass spectrometric characterization of efaproxiral (RSR13) and its implementation into doping controls using liquid chromatography-atmospheric pressure ionization-tandem mass spectrometry.Mass spectrometry in sports drug testing: Structure characterization and analytical assays.Liquid chromatographic-mass spectrometric analysis of glucuronide-conjugated anabolic steroid metabolites: method validation and interlaboratory comparison.Doping control analysis of methoxyphenamine using liquid chromatography-tandem mass spectrometry.Identification and characterization of in vitro and in vivo generated metabolites of the adiponectin receptor agonists AdipoRon and 112254.Identification of selected in vitro generated phase-I metabolites of the steroidal selective androgen receptor modulator MK-0773 for doping control purposes.Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing.Synthesis, characterisation, and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes.Analysis of octopamine in human doping control samples.Mildronate (Meldonium) in professional sports - monitoring doping control urine samples using hydrophilic interaction liquid chromatography - high resolution/high accuracy mass spectrometry.Structure elucidation of the diagnostic product ion at m/z 97 derived from androst-4-en-3-one-based steroids by ESI-CID and IRMPD spectroscopy.Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis.Investigations on changes in ¹³C/¹²C ratios of endogenous urinary steroids after pregnenolone administration.Trafficking of drug candidates relevant for sports drug testing: detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet.Metabolism of growth hormone releasing peptides.Annual banned-substance review: analytical approaches in human sports drug testing.Identification of the aromatase inhibitors anastrozole and exemestane in human urine using liquid chromatography/tandem mass spectrometry.Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes.Determination of tuaminoheptane in doping control urine samples.Temporal indication of cannabis use by means of THC glucuronide determination.Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis.Mass spectrometry of hydantoin-derived selective androgen receptor modulators.Determination of benzimidazole- and bicyclic hydantoin-derived selective androgen receptor antagonists and agonists in human urine using LC-MS/MS.Factors influencing the steroid profile in doping control analysis.Detection of recombinant growth hormone in human plasma by a 2-D PAGE method.Doping control analysis of metamfepramone and two major metabolites using liquid chromatography-tandem mass spectrometry.Complementing the characterization of in vivo generated N-glucuronic acid conjugates of stanozolol by collision cross section computation and analysis.Pharmacokinetics and in vitro efficacy of salicylic acid after oral administration of acetylsalicylic acid in horses.Prediction of human dietary δ15N intake from standardised food records: validity and precision of single meal and 24-h diet data.Detection of manipulation in doping control urine sample collection: a multidisciplinary approach to determine identical urine samples.Current role of LC-MS(/MS) in doping control.
P50
Q28209611-C00BF8C1-FBC5-490D-A949-E0E89A469A68Q30390786-29260C6E-7029-4BBF-AB63-C5D7A7180D5EQ31164243-2A5E1CC6-CDD8-402B-ACEB-07B33F2AF80FQ33265441-B2FDE08D-D1E3-460D-911E-0120BB6FC562Q33302814-D0AE97D6-FC7B-4C2C-80E4-A95BF2F4E857Q33313601-BEBBA9B8-AABB-4B0D-9E90-D436B3F35EE9Q33324266-286A5B90-BAEC-4C7F-8974-CD12498BF430Q33431949-389632E9-1BD2-4A07-B288-DF91B33A467AQ33433141-E0CC066D-C300-4014-8A0E-2B5B01D77F32Q33434659-1F63D342-FD11-4407-8659-351367CEF384Q33435735-E9E9571F-B140-4557-A3D4-93619520708DQ33440073-650FEFEB-CEF1-4527-A1CA-7EB77BAE284CQ33440529-4342CA5C-3473-4EC2-BC7A-8A7ED262AA9FQ33467518-A22DF0FC-F1CE-4FF4-BB77-191B8B0FD8D5Q33468414-E7C0BE26-33A0-4E97-B75D-FBEE0D9DA877Q33859587-D718A5B6-4787-4C9E-913A-C46E75B8457DQ33944531-B570238D-42F1-4672-9777-D093B2ACC696Q34024311-3097596D-5EBC-46D6-A4B2-4CD637BFD055Q34043669-F783FE04-9DDC-42C1-8434-B70CB2FE690BQ34102510-D611A42C-8317-4A1C-8469-A3A593FD9004Q34169514-B5603DBA-086B-440D-9C1C-419AD4A694E0Q34182098-246B104A-6BF0-42CF-83FE-E6E6CAC7AE7CQ34182103-0B30E79D-94D3-4E79-9E27-CE01F699F1CBQ34458391-F04D6056-7834-476B-BADC-BC015FA38430Q34509038-9DBA0C88-D581-4455-BBC6-17C63E807023Q34567702-51627B96-D652-4FDA-87D2-54651C3DD58BQ34575235-07902420-B20A-4BC1-A995-3D621FDE142EQ34583136-C6C6AB68-8400-460E-B871-6529D52F0CC3Q34618371-AD71F4B3-DCAC-4426-B2B4-7A975F6EADFDQ34710698-CE50F547-85D6-46EF-9BF8-6E56AC23BC5BQ34728033-04A10DB7-C9EF-4924-9C4F-1CD3096C08D5Q34749565-61BCCE8E-1FD3-4087-A12B-89BADD35BD8EQ34788041-18F6DEBF-492F-4685-8F36-02BF9FAA62A7Q34878291-966C5D0A-B9DE-4BA9-B6C3-EA74593A04CDQ34996085-D5807CEF-925E-4C08-ADB0-D9D9CFD4F8BBQ35826591-89AA2FD3-358C-4E2D-A620-068B7250EBE3Q36254572-E1FA4C33-045A-4671-8B5B-955E9648ABDBQ36307666-9577DE6C-4529-42B4-9028-93A7607270BBQ36721013-3F10808F-CF29-4528-9707-5BFF449A5201Q36723278-C2B6457D-45BD-48BC-8D17-34C5CD47C8E7
P50
description
deutscher Biochemiker, Sportwissenschaftler und Hochschullehrer
@de
scheikundige
@nl
name
Wilhelm Schänzer
@ast
Wilhelm Schänzer
@de
Wilhelm Schänzer
@en
Wilhelm Schänzer
@nl
Wilhelm Schänzer
@sl
type
label
Wilhelm Schänzer
@ast
Wilhelm Schänzer
@de
Wilhelm Schänzer
@en
Wilhelm Schänzer
@nl
Wilhelm Schänzer
@sl
prefLabel
Wilhelm Schänzer
@ast
Wilhelm Schänzer
@de
Wilhelm Schänzer
@en
Wilhelm Schänzer
@nl
Wilhelm Schänzer
@sl
P214
P227
P106
P1284
01000004859
P19
P21
P213
0000 0001 0992 0557
P214
P227
P31
P569
1951-11-14T00:00:00Z
P735
P7859
viaf-79278210